Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.19.3
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 5,560 $ 123,476,102 $ (65,698,101) $ 57,783,561
Balance, shares at Dec. 31, 2017 55,603,427    
Issuance of common stock, net of issuance costs $ 150 11,235,170 $ 11,235,320
Issuance of common stock, net of issuance costs, shares 1,500,000      
Stock-based compensation expense 5,659,928 5,659,928
Issuance of common stock upon exercise of warrants $ 1 4,999 5,000
Issuance of common stock upon exercise of warrants, shares 5,000      
Issuance of common stock upon exercise of stock options $ 13 337,632 337,645
Issuance of common stock upon exercise of stock options, shares 129,069      
Fair value of warrant issued in connection with Investment Agreement 6,215,225 6,215,225
Net loss (38,365,947) (38,365,947)
Balance at Sep. 30, 2018 $ 5,724 146,929,056 (104,064,048) 42,870,732
Balance, shares at Sep. 30, 2018 57,237,496      
Balance at Jun. 30, 2018 $ 5,719 144,942,278 (89,462,837) 55,485,160
Balance, shares at Jun. 30, 2018 57,192,496      
Stock issuance costs (11,512) (11,512)
Stock-based compensation expense 1,958,917 1,958,917
Issuance of common stock upon exercise of warrants $ 1 4,999 5,000
Issuance of common stock upon exercise of warrants, shares 5,000      
Issuance of common stock upon exercise of stock options $ 4 34,374 34,378
Issuance of common stock upon exercise of stock options, shares 40,000      
Net loss (14,601,211) (14,601,211)
Balance at Sep. 30, 2018 $ 5,724 146,929,056 (104,064,048) 42,870,732
Balance, shares at Sep. 30, 2018 57,237,496      
Balance at Dec. 31, 2018 $ 5,725 $ 148,888,635 $ (121,370,240) $ 27,524,120
Balance, shares at Dec. 31, 2018 57,247,496
Issuance of common stock, net of issuance costs $ 620 $ 37,718,078 $ 37,718,698
Issuance of common stock, net of issuance costs, shares 6,198,500      
Stock-based compensation expense 8,884,001 8,884,001
Issuance of common stock upon exercise of warrants $ 112 (112)
Issuance of common stock upon exercise of warrants, shares 1,119,868      
Issuance of common stock upon exercise of stock options $ 10 $ 386,801 $ 386,811
Issuance of common stock upon exercise of stock options, shares 107,029 107,029
Net loss $ (44,872,957) $ (44,872,957)
Balance at Sep. 30, 2019 $ 6,467 195,877,403 (166,243,197) 29,640,673
Balance, shares at Sep. 30, 2019 64,672,893      
Balance at Jun. 30, 2019 $ 6,465 $ 192,819,731 $ (145,452,396) $ 47,373,800
Balance, shares at Jun. 30, 2019 64,644,093
Stock-based compensation expense $ 2,977,574 $ 2,977,574
Issuance of common stock upon exercise of stock options $ 2 80,098 80,100
Issuance of common stock upon exercise of stock options, shares 28,800      
Net loss (20,790,801) (20,790,801)
Balance at Sep. 30, 2019 $ 6,467 $ 195,877,403 $ (166,243,197) $ 29,640,673
Balance, shares at Sep. 30, 2019 64,672,893